Prevalencia de dislipidemias en población militar que acude a revisión médica anual
Contenido principal del artículo
Resumen
Las dislipidemias juegan un papel crucial en la génesis de la ateroesclerosis, como se ha demostrado en estudios epidemiológicos de enfermedades cardiovasculares.
Detalles del artículo
Sección
Cómo citar
Referencias
Mahley RW, Weisgraber KH, Farese RV Jr. Disorders of Lipid Metabolism. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS
(eds.). Williams Textbook of Endocrinology. 10th Ed. Saunders; 2003, 34, p. 1642705.
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the Natio nal Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high cholesterol. JAMA 2001; 285: 248697.
Brunzell JD. Hypertriglyceridemia. N Engl J Med 2007; 357: 100917.
AguilarSalinas CA, GómezPérez FJ, LermanGarber I, Vázquez Chávez C, PérezMéndez O, PosadasRomero C. Diagnóstico y tratamien to de las dislipidemias: posición de la Sociedad Mexicana de Nutrición y Endocrinología. Rev End y Nut 2004; 12(1): 741.
AguilarSalinas CA, Olaiz G, Valles V, Rios JM, Gomez PFJ, Rull JA, Rojas R, Franco A, Sepúlveda J. High prevalence of low HDL coleste rol concentrations and mixed hyperlipidemia in a Mexican nation wide survey. J Lipid Research 2001; 42: 1298307.
PérezMéndez O, Luc G, PosadasRomero C. Low concentrations of highdensity lipoproteins (HDL) in plasma and coronary artery disease. Arch Inst Cardiol Mex 2000; 70: 31221.
American College of Physicians. Guidelines for using serum cho lesterol, high density lipoprotein cholesterol and triglyceride levels as scree ning test for preventing coronary heart disease in adults. Ann Intern Med 1996; 124: 5147.
PosadasRomero C, TapiaConyer R, LermanGarber I, et al. Cho lesterol levels and prevalence of hypercholesterolemia in a Mexican adult population. Atherosclerosis 1995; 118: 27584.
Durrington P. Dyslipidemia. Lancet 2003; 362: 71731.
VillarrealMolina MT. Bases genéticas de la variación en los nive les plasmáticos de HDLcolesterol. Rev Endocr y Nut 2008; 16(1): 3241.
Gordon DJ, Rifkind BM. HighDensity Lipoprotein: the clinical implications of recent studies. N Engl J Med 1989; 321: 13116.
Genest J, Pedersen TR. Prevention of cardiovascular ischemic events: highrisk and secondary prevention. Circulation 2003; 107:
Genest J Jr, Marcil M, Denis M, Yu L. High density lipoproteins in health and in disease. J Investig Med 1999; 47: 3142.
Gotto AM Jr, Brinton EA. Assessing low levels of highdensity lipoprotein cholesterol as a risk factor in coronary heart disease: a wor king group report and update. J Am Coll Cardiol 2004; 43: 71724.
Peacock JM, Arnett DK, Atwood LD, Myers RH, Coon H, Rich SS, Province MA, Heiss G. Genome scan for quantitative trait loci linked to highdensity lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 2001; 21: 18238.
Reaven G. Banting Lecture: role of insulin resistance in human disease. Diabetes 1988; 37: 1595607.
Garrison RJ, Kannel WB, Feinleib M, et al. Cigarette smoking and HDL cholesterol. The Framingham Offspring Study. Atherosclerosis 1978;
: 1725.
Castelli WP, Doyle JT, Gordon T, et al. Alcohol and blood lipids: the Cooperative Lipoprotein Phenotyping Study. Lancet 1977; ii: 1535.
MartínezLara E, FloresBello, et al. Prevalencia del síndrome metabólico en población militar que acude a valoración médica anual. Rev Sanid Milit Mex 2007; 61(6): 3616.
Walldius G, Junger I, Holme I, et al. High apolipoprotein B, low apolipoprotein A1, and improvement in the prediction of fatal myocar dial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 202633.
MartínezLara E, OlivaresAlvarado D, MendozaSoto JC, Millán Juárez A. Dislipidemias e índice aterogénico elevado relacionado con el desarrollo de glaucoma primario de ángulo abierto. Rev Sanid Milit Mex 2005; 59 (1): 14.